APA (7th ed.) Citation

Q, S., WZ, H., CK, H., Y, H., LR, M., & Q, W. (2026). Ketone Body Metabolism and Sodium Glucose Cotransporter 2 Inhibitor Response in Heart Failure With Ischemic Cause: A Precision Medicine Approach Using Metabolomics Integration With Global Burden of Disease Population Data Across Diverse Genetic Backgrounds. Journal of the American Heart Association, 15(12), e048427. https://doi.org/10.1161/JAHA.125.048427

Chicago Style (17th ed.) Citation

Q, Su, Huang WZ, Hu CK, Huang Y, Mo LR, and Wu Q. "Ketone Body Metabolism and Sodium Glucose Cotransporter 2 Inhibitor Response in Heart Failure With Ischemic Cause: A Precision Medicine Approach Using Metabolomics Integration With Global Burden of Disease Population Data Across Diverse Genetic Backgrounds." Journal of the American Heart Association 15, no. 12 (2026): e048427. https://doi.org/10.1161/JAHA.125.048427.

MLA (9th ed.) Citation

Q, Su, et al. "Ketone Body Metabolism and Sodium Glucose Cotransporter 2 Inhibitor Response in Heart Failure With Ischemic Cause: A Precision Medicine Approach Using Metabolomics Integration With Global Burden of Disease Population Data Across Diverse Genetic Backgrounds." Journal of the American Heart Association, vol. 15, no. 12, 2026, p. e048427, https://doi.org/10.1161/JAHA.125.048427.